SCHEMBL4254844

SCHEMBL4254844

Nc1cc(N)nc(Br)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28302673 0.81 — —
SCHEMBL4650449 0.81 — —
SCHEMBL28303960 0.75 NOS2 (0.55) —
SCHEMBL14920316 0.75 ALDH1A1 (0.38) —
SCHEMBL28303965 0.75 NOS2 (0.55) —
SCHEMBL28303959 0.74 HRH4 (0.38) —
SCHEMBL8499815 0.73 — —
SCHEMBL1181671 0.73 — —
SCHEMBL96485 0.72 — —
SCHEMBL27855379 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101687789-A Novel inhibitors hepatitis c virus replication INTERMUNE INC 2010-03-31 — — CN disclosed
EP-2134683-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2009-12-23 — — EP disclosed
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-02-19 — — US disclosed
WO-2008100867-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-08-21 — — WO disclosed
Send feedback